{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T22:56:02Z","timestamp":1763333762506,"version":"3.45.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,16]]},"DOI":"10.7759\/cureus.96993","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T22:51:36Z","timestamp":1763333496000},"source":"Crossref","is-referenced-by-count":0,"title":["A Rare Presentation of Metastatic Prostate Cancer With Recurrent Malignant Ascites: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Yanming","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunydip","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Zangui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel RL","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024, 74:12-49. 10.3322\/caac.21820","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/pros.22742","article-title":"Distribution of metastatic sites in patients with prostate cancer: a population-based analysis","volume":"74","author":"Gandaglia G","year":"2014","unstructured":"Gandaglia G, Abdollah F, Schiffmann J, et al.. Distribution of metastatic sites in patients with prostate cancer: a population-based analysis. Prostate. 2014, 74:210-6. 10.1002\/pros.22742","journal-title":"Prostate"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199402033300508","article-title":"Care of patients with ascites","volume":"330","author":"Runyon BA","year":"1994","unstructured":"Runyon BA. Care of patients with ascites. N Engl J Med. 1994, 330:337-42. 10.1056\/NEJM199402033300508","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-012-0396-6","article-title":"Malignant ascites: pathophysiology and treatment","volume":"18","author":"Cavazzoni E","year":"2013","unstructured":"Cavazzoni E, Bugiantella W, Graziosi L, Franceschini MS, Donini A. Malignant ascites: pathophysiology and treatment. Int J Clin Oncol. 2013, 18:1-9. 10.1007\/s10147-012-0396-6","journal-title":"Int J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.eucr.2020.101414","article-title":"Isolated non-ascitic peritoneal carcinomatosis after robotic radical prostatectomy for prostate cancer: a case report","volume":"33","author":"El Khoury MB","year":"2020","unstructured":"El Khoury MB, Van Eycken M, Roumegu\u00e8re T, Albisinni S. Isolated non-ascitic peritoneal carcinomatosis after robotic radical prostatectomy for prostate cancer: a case report. Urol Case Rep. 2020, 33:101414. 10.1016\/j.eucr.2020.101414","journal-title":"Urol Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2663-1","article-title":"The peritoneal \"soil\" for a cancerous \"seed\": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases","volume":"75","author":"Miku\u0142a-Pietrasik J","year":"2018","unstructured":"Miku\u0142a-Pietrasik J, Uruski P, Tykarski A, Ksi\u0105\u017cek K. The peritoneal \"soil\" for a cancerous \"seed\": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci. 2018, 75:509-25. 10.1007\/s00018-017-2663-1","journal-title":"Cell Mol Life Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jso.27890","article-title":"Pathophysiology of peritoneal metastasis","volume":"130","author":"Demuytere J","year":"2024","unstructured":"Demuytere J, Ernst S, Ceelen W. Pathophysiology of peritoneal metastasis. J Surg Oncol. 2024, 130:1299-305. 10.1002\/jso.27890","journal-title":"J Surg Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney CJ","year":"2015","unstructured":"Sweeney CJ, Chen YH, Carducci M, et al.. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. 2015, 373:737-46. 10.1056\/NEJMoa1503747","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01037-5","article-title":"Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial","volume":"387","author":"James ND","year":"2016","unstructured":"James ND, Sydes MR, Clarke NW, et al.. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet. 2016, 387:1163-77. 10.1016\/S0140-6736(15)01037-5","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61389-X","article-title":"Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial","volume":"376","author":"De Bono JS","year":"2010","unstructured":"De Bono JS, Oudard S, Ozguroglu M, et al.. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet. 2010, 376:1147-54. 10.1016\/S0140-6736(10)61389-X","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.72.1076","article-title":"Phase III study comparing a reduced dose of cabazitaxel (20 mg\/m2) and the currently approved dose (25 mg\/m2) in postdocetaxel patients with metastatic castration-resistant prostate cancer-PROSELICA","volume":"35","author":"Eisenberger M","year":"2017","unstructured":"Eisenberger M, Hardy-Bessard AC, Kim CS, et al.. Phase III study comparing a reduced dose of cabazitaxel (20 mg\/m2) and the currently approved dose (25 mg\/m2) in postdocetaxel patients with metastatic castration-resistant prostate cancer-PROSELICA. J Clin Oncol. 2017, 35:3198-206. 10.1200\/JCO.2016.72.1076","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/jpm.2024.0140","article-title":"Ascites as a predictive factor in malignancies in the last year of life-comparison between different cancer types","volume":"28","author":"Fridegren J","year":"2025","unstructured":"Fridegren J, Bj\u00f6rkhem-Bergman L, Schultz T, Strang P. Ascites as a predictive factor in malignancies in the last year of life-comparison between different cancer types. J Palliat Med. 2025, 28:35-41. 10.1089\/jpm.2024.0140","journal-title":"J Palliat Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.1970","article-title":"Survival in patients with de novo metastatic prostate cancer","volume":"7","author":"Schoen MW","year":"2024","unstructured":"Schoen MW, Montgomery RB, Owens L, Khan S, Sanfilippo KM, Etzioni RB. Survival in patients with de novo metastatic prostate cancer. JAMA Netw Open. 2024, 7:e241970. 10.1001\/jamanetworkopen.2024.1970","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/cytojournal.cytojournal_37_18","article-title":"Use of the term atypical cells in the reporting of ascitic fluid cytology: a caveat","volume":"16","author":"Pai RR","year":"2019","unstructured":"Pai RR, Shenoy KD, Minal J, Suresh PK, Chakraborti S, Lobo FD. Use of the term atypical cells in the reporting of ascitic fluid cytology: a caveat. Cytojournal. 2019, 16:13. 10.4103\/cytojournal.cytojournal_37_18","journal-title":"Cytojournal"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2024.0019","article-title":"NCCN guidelines\u00ae insights: prostate cancer, version 3.2024","volume":"22","author":"Schaeffer EM","year":"2024","unstructured":"Schaeffer EM, Srinivas S, Adra N, et al.. NCCN guidelines\u00ae insights: prostate cancer, version 3.2024. J Natl Compr Canc Netw. 2024, 22:140-50. 10.6004\/jnccn.2024.0019","journal-title":"J Natl Compr Canc Netw"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2021.05.026","article-title":"Novel case of isolated peritoneal carcinomatosis from metastatic prostate cancer carrying a pathogenic BRCA mutation treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"155","author":"King MC","year":"2021","unstructured":"King MC, Sardi A, Velez-Mejia C, Sittig M, Ledakis P. Novel case of isolated peritoneal carcinomatosis from metastatic prostate cancer carrying a pathogenic BRCA mutation treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Urology. 2021, 155:210-3. 10.1016\/j.urology.2021.05.026","journal-title":"Urology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107322","article-title":"Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer","volume":"385","author":"Sartor O","year":"2021","unstructured":"Sartor O, de Bono J, Chi KN, et al.. Lutetium-177-PSMA-617 for metastatic castration-resistant prostate cancer. N Engl J Med. 2021, 385:1091-103. 10.1056\/NEJMoa2107322","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5489\/cuaj.547","article-title":"Metastatic prostate cancer with malignant ascites: a case report and literature review","volume":"7","author":"Ani I","year":"2013","unstructured":"Ani I, Costaldi M, Abouassaly R. Metastatic prostate cancer with malignant ascites: a case report and literature review. Can Urol Assoc J. 2013, 7:E248-50. 10.5489\/cuaj.547","journal-title":"Can Urol Assoc J"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.12890\/2020_001474","article-title":"An improbable case of ascites","volume":"7","author":"Visconti V","year":"2020","unstructured":"Visconti V, Fernandes A, Oliveira I. An improbable case of ascites. Eur J Case Rep Intern Med. 2020, 7:001474. 10.12890\/2020_001474","journal-title":"Eur J Case Rep Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2014.05.002","article-title":"An unusual presentation of a patient with advanced prostate cancer, massive ascites and peritoneal metastasis: case report and literature review","volume":"6","author":"Petrakis D","year":"2015","unstructured":"Petrakis D, Pentheroudakis G, Kamina S, Pappa L, Papadiotis E, Malamou-Mitsi V, Pavlidis N. An unusual presentation of a patient with advanced prostate cancer, massive ascites and peritoneal metastasis: case report and literature review. J Adv Res. 2015, 6:517-21. 10.1016\/j.jare.2014.05.002","journal-title":"J Adv Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.121639.1","article-title":"Case report: a rare presentation of prostate cancer with peritoneal carcinomatosis and malignant ascites complicated by tumor lysis syndrome","volume":"11","author":"Venkateswaran AR","year":"2022","unstructured":"Venkateswaran AR, Elzein SF, Sulpizio ED, Chang B, Kosty MP. Case report: a rare presentation of prostate cancer with peritoneal carcinomatosis and malignant ascites complicated by tumor lysis syndrome. F1000Res. 2022, 11:957. 10.12688\/f1000research.121639.1","journal-title":"F1000Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.4222","article-title":"Prostate cancer metastatic to the peritoneum: a road less traveled by a common malignancy","volume":"11","author":"Tareen SA","year":"2019","unstructured":"Tareen SA, Rodriguez J, Wu P. Prostate cancer metastatic to the peritoneum: a road less traveled by a common malignancy. Cureus. 2019, 11:e4222. 10.7759\/cureus.4222","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)00779-3","article-title":"Hemorrhagic ascites: an unusual manifestation of prostate carcinoma","volume":"111","author":"Tsai JY","year":"2001","unstructured":"Tsai JY, Ling M, Chang VT, Hwang SS, Kasimis BS. Hemorrhagic ascites: an unusual manifestation of prostate carcinoma. Am J Med. 2001, 111:245-6. 10.1016\/S0002-9343(01)00779-3","journal-title":"Am J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/curroncol29070351","article-title":"Isolated peritoneal metastasis of prostate cancer presenting with massive ascites: a case report","volume":"29","author":"Jang HR","year":"2022","unstructured":"Jang HR, Lee K, Lim KH. Isolated peritoneal metastasis of prostate cancer presenting with massive ascites: a case report. Curr Oncol. 2022, 29:4423-7. 10.3390\/curroncol29070351","journal-title":"Curr Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.4103\/2394-4722.152767","article-title":"Malignant ascites with omental metastasis: a rare event in prostate cancer","volume":"1","author":"Saini R","year":"2015","unstructured":"Saini R, Dodagoudar C, Talwar V, Singh S. Malignant ascites with omental metastasis: a rare event in prostate cancer. J Cancer Metastasis Treat. 2015, 1:34-5. 10.4103\/2394-4722.152767","journal-title":"J Cancer Metastasis Treat"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.65405","article-title":"Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: a case report and review of literature","volume":"26","author":"Benedict SP","year":"2010","unstructured":"Benedict SP, Ahuja M, Mammen KJ. Hormone refractory carcinoma prostate with peritoneal metastases and malignant ascites without skeletal involvement: a case report and review of literature. Indian J Urol. 2010, 26:287-8. 10.4103\/0970-1591.65405","journal-title":"Indian J Urol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-230899","article-title":"Pigs in a blanket: an unusual presentation of malignant ascites in prostatic adenocarcinoma","volume":"12","author":"Samankan S","year":"2019","unstructured":"Samankan S, Taherian M, Aghighi M, Crossland D. Pigs in a blanket: an unusual presentation of malignant ascites in prostatic adenocarcinoma. BMJ Case Rep. 2019, 12:10.1136\/bcr-2019-230899","journal-title":"BMJ Case Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/23155.8837","article-title":"Malignant ascites due to prostatic adenocarcinoma: an extremely rare manifestation of a common disease","volume":"10","author":"Papadatos SS","year":"2016","unstructured":"Papadatos SS, Bazoukis G, Deligiannis G, Mylonas S, Zissis C. Malignant ascites due to prostatic adenocarcinoma: an extremely rare manifestation of a common disease. J Clin Diagn Res. 2016, 10:OL01. 10.7860\/JCDR\/2016\/23155.8837","journal-title":"J Clin Diagn Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-024-04543-x","article-title":"The effect of unusual presentation on delayed diagnosis of prostate cancer: a case series","volume":"18","author":"Oyortey MA","year":"2024","unstructured":"Oyortey MA, Adanu KK, Ali MA. The effect of unusual presentation on delayed diagnosis of prostate cancer: a case series. J Med Case Rep. 2024, 18:256. 10.1186\/s13256-024-04543-x","journal-title":"J Med Case Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2012-008388","article-title":"Prostate cancer with metastases to the kidney: a rare manifestation of a common disease","volume":"2013","author":"Khan F","year":"2013","unstructured":"Khan F, Mahmalji W, Sriprasad S, Madaan S. Prostate cancer with metastases to the kidney: a rare manifestation of a common disease. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2012-008388","journal-title":"BMJ Case Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428254-a-rare-presentation-of-metastatic-prostate-cancer-with-recurrent-malignant-ascites-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T22:51:36Z","timestamp":1763333496000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428254-a-rare-presentation-of-metastatic-prostate-cancer-with-recurrent-malignant-ascites-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,16]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.96993","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,16]]}}}